Roswell Park Cancer Institute (RPCI), America’s first cancer center founded in 1898, is a National Cancer Institute-designated National Comprehensive Cancer Center (NCCN) serving the greater Western New York area. The institution provides patient care to 133 inpatient beds and has 31,000+ patients under current active care with over 201,000 outpatient visits per year. RPCI is a well-known for the strengths of its clinical staff, translational research and multidisciplinary oncology teams.
Currently the Institution has an academic affiliation with The State University of New York at Buffalo. Approximately 60 percent of RPCI's 25-acre campus has undergone major renovation or has been newly built since 1998. A new Center for Genetics and Pharmacology opened in the spring of 2006 alongside the newly constructed New York State Center of Excellence in Bioinformatics and Life Sciences. In addition, a satellite infusion center located in Amherst, NY started accepting patients in the fall of 2006 and a new phase I unit opened in 2008.
RPCI was ranked among the 50 best cancer hospitals in U.S. News & World Report’s “2015-16 Best Hospitals-Cancer” list.
To serve our patients and to support our health care professionals through providing the highest quality pharmaceutical care, education, and research
To provide essential support for Roswell Park Cancer Institute to rank in the top 10 of the Nation’s cancer centers